SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a sharp selloff across AI neocloud stocks, as traders debate financing costs, debt exposure and whether providers can earn acceptable returns on their infrastructure buildouts. Bulls see the decline as an oversold sector pullback and cite insider buying and persistent AI-compute demand, while bears warn that the business model and broader AI trade remain risky.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy is fueling a rebound debate after a steep selloff tied to concerns about the companys debt burden, borrowing costs, and financing needs. Bullish traders view the upgrade and AI demand as support for recovery, while skeptics argue that credit-market stress and heavy leverage remain serious risks.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The prolonged wait for the 80th death event in SELLASs blinded Phase 3 REGAL AML triallast reported at 78 of 80has traders speculating that survival is extended and results could be presented around ASH. Others caution that the delay and CEOs anniversary post do not establish trial success or an imminent deal, amid a sharp share decline; SLS009 data is another, secondary focus.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

WULF is drawing attention amid a sharp selloff in AI-infrastructure stocks and a Morgan Stanley report arguing its decline is out of line with its contracts and potential catalysts. Traders disagree on whether financing, debt and sector concerns outweigh the companys power-and-data-center model, with some viewing the heavy-volume rebound and CEO defense of that model as signs of a possible recovery.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is under heavy selling pressure alongside AI data-center and neocloud stocks, as traders focus on CoreWeaves credit concerns, higher borrowing costs, and uncertainty about financing APLDs expansion. The debate contrasts concerns over debt, dilution, and execution with bullish views pointing to insider buying, contracted leases, and delivered capacity.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is drawing attention after stronger-than-guided Q3 results and a more upbeat 2027 adjusted EBITDA outlook. Bulls cite improving operations and possible short covering, while skeptics question whether earnings gains can overcome the companys substantial debt.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Traders are reacting to EyePoints reported decision to end its pivotal wet-AMD trials and cut its workforce, with debate over whether that reduces competition for Ocular Therapeutix or reflects broader doubts about the retinal-drug market. Attention also remains on Axpaxlis regulatory path and the anticipated NDA filing.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

The FDA accepted CorMedixs supplemental REZZAYO application for priority review to expand use into preventing invasive fungal disease in transplant patients, with a target decision date in Q1 2027. Traders see the faster review and potential new indication as a growth catalyst, while noting that filing acceptance does not guarantee approval.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles announcement that Deutsche Telekom, Orange, Telefnica and Vodafone signed a letter of intent to explore a joint European satellite-spectrum bid is drawing attention, with traders viewing AST as a possible satellite partner. No provider has been selected, and optimism about the opportunity is tempered by concerns over launch timing, execution and the stocks steep decline.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumbles sharp selloff is fueling debate over whether its reported Anthropic AI-compute deal and data-center expansion can translate into revenue, with traders questioning financing, deal confirmation and managements communication. Bulls point to the AI infrastructure opportunity and heavy short interest, while bears cite execution risks and weakness across the sector; many are watching for clarity around financing and upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia

Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal Hyperplasia Neurocrine Biosciences Presents Real-World Evidence Mapping the Lifelong, Evolving Impact of Classic Congenital Adrenal HyperplasiaPR NewswireSAN DIEGO, Oct. 16, 2026...

Why Neurocrine Biosciences (NBIX) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?

NBIX vs. SDZNY: Which Stock Is the Better Value Option?

Why Neurocrine Biosciences (NBIX) is a Top Growth Stock for the Long-Term

Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results

Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial Results Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2026 Financial ResultsPR NewswireSAN DIEGO, Oct. 12, 2026Conference Call and Webcast Scheduled for Monday, November 2SAN...

4 CNS Drug Stocks Worth Watching This World Mental Health Day

AXSM, NBIX, ALKS and ACAD are advancing CNS treatments for mental health disorders, with growing product sales, pipeline progress and new growth opportunities.

Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference

Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference Neurocrine Biosciences to Present Research Advancing Understanding of...

Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer

Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical OfficerPR NewswireSAN DIEGO, Sept. 28, 2026 SAN DIEGO, Sept. 28, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced...

Neurocrine Biosciences to Present at Upcoming Investor Conferences in September

Neurocrine Biosciences to Present at Upcoming Investor Conferences in September Neurocrine Biosciences to Present at Upcoming Investor Conferences in September PR Newswire SAN DIEGO, Sept. 2, 2026 SAN DIEGO, Sept. 2, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced...

Neurocrine's Crenessity Gains Ground in CAH: How Far Can Sales Go?

NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

NBIX Stock Slips As $2.9B Soleno Deal Triggers Fresh Drug Safety Warnings 

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$135.71
Prev Close	$136.95
Open	$137.86
Dividend Yield	0.00%
50-Day Moving Average	$149.26
Beta	0.75
Avg. Volume	1.23M
PE Ratio	19.88

52-Week High	$186.12
52-Week Low	$122.14
Market Capitalization	$13.79B
EPS (Annual)	$4.67
Price to Book	3.73
Revenue Per Employee	$1.43M

Feed

News

Sentiment

Earnings

Fundamentals

Info

NBIX Fundamentals